Expression of cysteine proteinases and metalloproteinases and their specific inhibitors in inflammatory joint diseases.

被引：0
|
作者：
Redlich, A
Haupl, T
Sparmann, M
Zacher, J
Ungethum, U
Keysser, G
Burmester, GR
机构：
[1] HUMBOLDT UNIV BERLIN,DEPT MED 3,D-10098 BERLIN,GERMANY
[2] IMMANUEL KRANKENHAUS,DEPT ORTHOPED,D-14109 BERLIN,GERMANY
[3] KLINIKUM BUCH,DEPT ORTHOPED,D-13125 BERLIN,GERMANY
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1312 / 1312
页数：1
相关论文
共 50 条
  • [31] Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction
    Uchibori, M
    Nishida, Y
    Tabata, I
    Sugiura, H
    Nakashima, H
    Yamada, Y
    Ishiguro, N
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (01) : 110 - 119
  • [32] Discovery of novel carboxylated, heteroaryl-substituted chalcones as inhibitors of VCAM-1 expression for use in chronic inflammatory diseases.
    Meng, CQ
    Ni, LM
    Worsencroft, KJ
    Ye, ZH
    Weingarten, MD
    Simpson, JE
    Skudlarek, JW
    Marino, EM
    Suen, KL
    Kunsch, C
    Howard, RB
    Sundell, CL
    Wasserman, MA
    Sikorski, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U219 - U219
  • [33] Expression and regulation of metalloproteinases-2,-9 and tissue inhibitors of metallo-proteinases in rat corpus luteum
    YU Xiaoguang
    Laboratory of Reproductive Endocrinology
    Chinese Science Bulletin, 2002, (12) : 1011 - 1014
  • [34] Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis
    Kaneko, M
    Tomita, T
    Nakase, T
    Ohsawa, Y
    Seki, H
    Takeuchi, E
    Takano, H
    Shi, K
    Takahi, K
    Kominami, E
    Uchiyama, Y
    Yoshikawa, H
    Ochi, T
    RHEUMATOLOGY, 2001, 40 (03) : 247 - 255
  • [35] Development of specific Kinase-Inhibitors for the Treatment of inflammatory Diseases
    Neubauer, G.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (12): : 690 - 690
  • [36] WANT SIGNALING MODULATORS EXPRESSION BY FLS IN INFLAMMATORY JOINT DISEASES
    Resende, G. G.
    Machado, C. R. L.
    Macedo, R. B., V
    Rocha, M. A.
    Nascimento, V. C.
    Bueno Filho, J. S. S.
    Kakehasi, A. M.
    Andrade, M. V. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 744 - 744
  • [37] Bone densitometry in inflammatory rheumatic diseases. Characteristics of the measurement site and disease-specific factors
    Franck, H.
    Braun, J.
    Buttgereit, F.
    Demary, W.
    Hein, G.
    Kekow, J.
    Schett, G.
    Kern, P. M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (10): : 845 - 850
  • [38] EFFECTS OF DYSMETABOLISMS AND COMORBIDITIES ON THE EFFICACY, SAFETY AND RETENTION RATE OF BIOLOGICAL DMARDS (BDMARD) IN INFLAMMATORY JOINT DISEASES.
    Cometi, L.
    Bruni, C.
    Chiti, N.
    Tofani, L.
    Nacci, F.
    Bartoli, F.
    Randone, S. Bellando
    Fiori, G.
    Guiducci, S.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1416 - 1416
  • [39] RESVERATROL DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY AND DEGENERATIVE JOINT DISEASES. EFFECTS ON FIBROBLAST-LIKE SYNOVIOCYTES AND CHONDROCYTES
    Breitenbach, J.
    Fischer, A.
    von Dalwigk, K.
    Sevelda, F.
    Goldhahn, K.
    Galardon, E.
    Toegel, S.
    Steiner, G.
    Kloesch, B.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S501 - S501
  • [40] Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
    Séguier, S
    Gogly, B
    Bodineau, A
    Godeau, G
    Brousse, N
    JOURNAL OF PERIODONTOLOGY, 2001, 72 (10) : 1398 - 1406
12345